Clinical Trial Update: CRIC Combined With MFT for Cardiovascular Adverse Events in Patients With Incomplete Revascularization of CAD [NA]

View source ↗

Summary

A clinical trial is currently recruiting to evaluate CRIC combined with MFT for preventing cardiovascular adverse events in patients with coronary artery diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CRIC
• MFT

Snippet

Sponsor: Henan Institute of Cardiovascular Epidemiology | Conditions: Coronary Artery Disease | NA | Status: RECRUITING